1.Over-expression of phospholipase D3 inhibits Akt phosphorylation in C2C12 myoblasts.
Junlin ZHANG ; Shuai CHEN ; Shujin ZHANG ; Zhijuan LU ; Heping YANG ; Huayan WANG
Chinese Journal of Biotechnology 2009;25(10):1524-1531
Phospholipase D (PLD) hydrolyzes phosphocholine into choline and phosphatide acid, and these metabolites play an important role in regulating cell physiology and biochemistry. To study the biological function of phospholipase D3 (PLD3) during the insulin stimulation in C2C12 myoblasts, we constructed PLD3 over-expressed cell lines (C2C12/pPLD3) and investigated the phosphorylation of Akt. The results showed that the level of phosphorylated Akt (P-Akt) was significantly increased in control C2C12 cells when insulin concentration was elevated during cell treatment, whereas the level of P-Akt in C2C12/pPLD3 cells was not changed. When extending the time of insulin treatment, P-Akt level in C2C12/pPLD3 cells was increased around 2 folds, but the total level of P-Akt in C2C12/pPLD3 was still lower than that in control group. 1-Butanol, a PLD inhibitor, could completely block Akt phosphorylation in C2C12 cells that even stimulated by insulin. However, 1-Butanol did not inhibit the Akt phosphorylation in C2C12/pPLD3 cells, but increased the phosphorylation up to 6 folds higher than control cells. The level of Akt phosphorylation in control C2C12 cells was increased significantly when stimulated by phosphatidic acid (PA), while there was no change in C2C12/pPLD3 cells with the similar treatment. When cells simulated by both PA and insulin, P-Akt level in both C2C12/pPLD3 cells and C2C12 cells were down regulated. Our observations indicated that PLD3 over expression may inhibit Akt phosphorylation and further block the transduction of insulin signaling in C2C12 cells.
Cell Line
;
Humans
;
Insulin
;
pharmacology
;
Myoblasts
;
cytology
;
metabolism
;
Phosphatidylinositol 3-Kinases
;
metabolism
;
Phospholipase D
;
biosynthesis
;
Phosphorylation
;
Proto-Oncogene Proteins c-akt
;
chemistry
;
drug effects
;
Signal Transduction
2.Major house dust mite allergen, Der p I, activates phospholipase D in human peripheral blood mononuclear cells from allergic patients: involvement of protein kinase C.
Jae Won OH ; Jong Hoon KIM ; Ki Sung LEE ; Joong Soo HAN
Experimental & Molecular Medicine 2000;32(2):67-71
The major house-dust-mite allergen, Der p I, stimulates the phospholipase D (PLD) in peripheral blood mononuclear cells (PBMC) from allergic patients with maximal responses after 30 min exposure. At 30 min, Der p I stimulated PLD activity by 1.4-fold in mild, 1.6-fold in moderate and 2-fold in severe allergic patients over control values (p < 0.05). When the cells were pretreated for 24 h with phorbol myristate acetate to down-regulate protein kinase C (PKC), PLD stimulation by Der p I was largely abolished. These results indicate that in PBMC from allergic patients, Der p I can stimulate PLD activity, and that PKC activation is involved in this stimulation.
Adult
;
Allergens/metabolism*
;
Allergens/immunology
;
Animal
;
Down-Regulation (Physiology)
;
Glycoproteins/metabolism*
;
Glycoproteins/immunology
;
Human
;
Hypersensitivity/metabolism
;
Hypersensitivity/immunology
;
Hypersensitivity/blood
;
IgE/blood
;
In Vitro
;
Leukocytes, Mononuclear/metabolism
;
Leukocytes, Mononuclear/immunology
;
Mites/metabolism
;
Mites/immunology
;
Phospholipase D/metabolism*
;
Phospholipase D/immunology
;
Protein Kinase C/metabolism*
;
Skin Tests
;
Tetradecanoylphorbol Acetate/pharmacology
3.Lysophosphatidylcholine suppresses apoptosis and induces neurite outgrowth in PC12 cells through activation of phospholipase D2.
Doo Hee YUN ; Eun Su JEON ; Sang Min SUNG ; Sung Ho RYU ; Jae Ho KIM
Experimental & Molecular Medicine 2006;38(4):375-384
Lysophosphatidylcholine (LPC) is a bioactive lipid generated by phospholipase A2-mediated hydrolysis of phosphatidylcholine. In the present study, we demonstrate that LPC stimulates phospholipase D2 (PLD2) activity in rat pheochromocytoma PC12 cells. Serum deprivation induced cell death of PC12 cells, as demonstrated by decreased viability, DNA fragmentation, and increased sub-G1 fraction of cell cycle. LPC treatment protected PC12 cells partially from the cell death and induced neurite outgrowth of the cells. Overexpression of PLD2 drastically enhanced the LPC-induced inhibition of apoptosis and neuritogenesis. Pretreatment of the cells with 1-butanol, a PLD inhibitor, completely abrogated the LPC-induced inhibition of apoptosis and neurite outgrowth in PC12 cells overexpressing PLD2. These results indicate that LPC possesses the neurotrophic effects, such as anti-apoptosis and neurite outgrowth, through activation of PLD2.
Starvation
;
Rats
;
Phospholipase D/antagonists & inhibitors/*metabolism
;
PC12 Cells
;
Neurites/*drug effects
;
Lysophosphatidylcholines/*pharmacology
;
Cell Survival/drug effects
;
Apoptosis/*drug effects
;
Animals
4.The expression and cellular localization of phospholipase D isozymes in the developing mouse testis.
Seungjoon KIM ; Heechul KIM ; Yongduk LEE ; Jin Won HYUN ; Young Ho LEE ; Min Kyoung SHIN ; Do Sik MIN ; Taekyun SHIN
Journal of Veterinary Science 2007;8(3):209-212
To examine the involvement of phospholipase D (PLD)isozymes in postnatal testis development, the expression ofPLD1 and PLD2 was examined in the mouse testis atpostnatal weeks 1, 2, 4, and 8 using Western blot analysisand immunohistochemistry. The expression of both PLD1and PLD2 increased gradually with development frompostnatal week 1 to 8. Immunohistochemically, PLDimmunoreactivity was detected in some germ cells in thetestis and interstitial Leydig cells at postnatal week 1.PLD was mainly detected in the spermatocytes andresidual bodies of spermatids in the testis after 8 weeksafter birth. The intense immunostaining of PLD in Leydigcells remained unchanged by postnatal week 8. Thesefindings suggest that PLD isozymes are involved in thespermatogenesis of the mouse testis.
Animals
;
Blotting, Western
;
Female
;
Immunohistochemistry
;
Isoenzymes
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Phospholipase D/biosynthesis/*metabolism
;
Spermatogenesis/physiology
;
Testis/*enzymology/growth & development
5.Phospholipase D2 promotes degradation of hypoxia-inducible factor-1alpha independent of lipase activity.
Mi Hee PARK ; Sun Sik BAE ; Kang Yell CHOI ; Do Sik MIN
Experimental & Molecular Medicine 2015;47(11):e196-
Hypoxia-inducible factor-1alpha (HIF-1alpha) is a key transcriptional mediator that coordinates the expression of various genes involved in tumorigenesis in response to changes in oxygen tension. The stability of HIF-1alpha protein is determined by oxygen-dependent prolyl hydroxylation, which is required for binding of the von Hippel-Lindau protein (VHL), the recognition component of an E3 ubiquitin ligase that targets HIF-1alpha for ubiquitination and degradation. Here, we demonstrate that PLD2 protein itself interacts with HIF-1alpha, prolyl hydroxylase (PHD) and VHL to promote degradation of HIF-1alpha via the proteasomal pathway independent of lipase activity. PLD2 increases PHD2-mediated hydroxylation of HIF-1alpha by increasing the interaction of HIF-1alpha with PHD2. Moreover, PLD2 promotes VHL-dependent HIF-1alpha degradation by accelerating the association between VHL and HIF-1alpha. The interaction of the pleckstrin homology domain of PLD2 with HIF-1alpha also promoted degradation of HIF-1alpha and decreased expression of its target genes. These results indicate that PLD2 negatively regulates the stability of HIF-1alpha through the dynamic assembly of HIF-1alpha, PHD2 and VHL.
Cell Line
;
HEK293 Cells
;
Humans
;
Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism
;
Phospholipase D/*metabolism
;
Prolyl Hydroxylases/metabolism
;
Proteasome Endopeptidase Complex/*metabolism
;
*Protein Interaction Maps
;
Proteolysis
;
Ubiquitin-Protein Ligases/metabolism
;
Von Hippel-Lindau Tumor Suppressor Protein/metabolism
6.Phospholipase D activates HIF-1-VEGF pathway via phosphatidic acid.
Songyi HAN ; Jeongsoon HUH ; Wooseong KIM ; Seongkeun JEONG ; Do Sik MIN ; Yunjin JUNG
Experimental & Molecular Medicine 2014;46(12):e126-
Growth factor-stimulated phospholipase D (PLD) catalyzes the hydrolysis of phosphatidylcholine (PC), generating phosphatidic acid (PA) which may act as a second messenger during cell proliferation and survival. Therefore, PLD is believed to play an important role in tumorigenesis. In this study, a potential mechanism for PLD-mediated tumorigenesis was explored. Ectopic expression of PLD1 or PLD2 in human glioma U87 cells increased the expression of hypoxia-inducible factor-1alpha (HIF-1alpha) protein. PLD-induced HIF-1 activation led to the secretion of vascular endothelial growth factor (VEGF), a HIF-1 target gene involved in tumorigenesis. PLD induction of HIF-1alpha was significantly attenuated by 1-butanol which blocks PA production by PLD, and PA per se was able to elevate HIF-1alpha protein level. Inhibition of mTOR, a PA-responsive kinase, reduced the levels of HIF-1alpha and VEGF in PLD-overexpressed cells. Epidermal growth factor activated PLD and increased the levels of HIF-1alpha and VEGF in U87 cells. A specific PLD inhibitor abolished expression of HIF-1alpha and secretion of VEGF. PLD may utilize HIF-1-VEGF pathway for PLD-mediated tumor cell proliferation and survival.
Cell Line, Tumor
;
Epidermal Growth Factor/metabolism
;
Gene Expression Regulation, Neoplastic
;
Glioma/genetics/*metabolism
;
Humans
;
Hypoxia-Inducible Factor 1, alpha Subunit/genetics/metabolism
;
Phosphatidic Acids/*metabolism
;
Phospholipase D/genetics/*metabolism
;
*Signal Transduction
;
Transfection
;
Vascular Endothelial Growth Factor A/*metabolism
7.Activation of epidermal growth factor receptor is responsible for pervanadate-induced phospholipase D activation.
Young Rae KIM ; Hyun Young CHA ; Kyu LIM ; Byung Doo HWANG ; Kwang Lae HOE ; Uk NAMGUNG ; Seung Kiel PARK
Experimental & Molecular Medicine 2003;35(2):118-124
Pervanadate, a complex of vanadate and H2O2, has an insulin mimetic effect, and acts as an inhibitor of protein tyrosine phosphatase. Pervanadate-induced phospholipase D (PLD) activation is known to be dependent on the tyrosine phosphorylation of cellular proteins and protein kinase C (PKC) activation, and yet underlying molecular mechanisms are not clearly understood. Here, we investigated the signaling pathway of pervanadate-induced PLD activation in Rat2 fibroblasts. Pervanadate increased PLD activity in dose- and time- dependent manner. Protein tyrosine kinase inhibitor, genistein, blocked PLD activation. Interestingly, AG-1478, a specific inhibitor of the tyrosine kinase activity of epidermal growth factor receptor (EGFR) blocked not only the PLD activation completely but also phosphorylation of p38 mitogen- activated protein kinase (MAPK). However, AG-1295, an inhibitor specific for the tyrosine kinase activity of pletlet drived growth factor receptor (PDGFR) did not show any effect on the PLD activation by pervanadate. We further found that pervanadate increased phosphorylation levels of p38, extracellular signal-regulated kinase (ERK) and c-Jun NH2-terminal kinase (JNK). SB203580, a p38 MAPK inhibitor, blocked the PLD activation completely. However, the inhibitions of ERK by the treatment of PD98059 or of JNK by the overexpression of JNK interacting peptide JBD did not show any effect on pervanadate-induced PLD activation. Inhibition or down-regulation of PKC did not alter the pervanadate-induced PLD activation in Rat2 cells. Thus, these results suggest that pervanadate-induced PLD activation is coupled to the transactivation of EGFR by pervanadate resulting in the activation of p38 MAP kinase.
Animals
;
Cell Line
;
Enzyme Activation/drug effects
;
Fibroblasts
;
Mitogen-Activated Protein Kinases/metabolism
;
Phospholipase D/*metabolism
;
Rats
;
Receptor, Epidermal Growth Factor/*agonists/*metabolism
;
Vanadates/*pharmacology
;
src-Family Kinases/metabolism
8.GPI-PLD inhibits the growth of hepatoma cells by down-regulation of PI3K-Akt signaling pathway.
Zhiying YANG ; Chaochao TAN ; Zhiping YANG ; He HUANG ; Jianhua TANG
Journal of Central South University(Medical Sciences) 2014;39(9):873-878
OBJECTIVE:
To clarify the effect of glycosylphosphatidylinositol-specific phospholipase D (GPIPLD) on hepatoma cells HepG2 and the possible molecular mechanism.
METHODS:
MTT, fluorescent staining and Western blot were applied to analyze the effect and molecular mechanism of GPI-PLD on hepatoma cells by transfected high expression GPI-PLD model. We inoculated HepG2 in nude mice models to further clarify the effect of GPI-PLD on hepatoma cells in vivo.
RESULTS:
Compared with the control groups, PI3K-Akt signaling pathway activity and proliferation of hepatoma cells were significantly inhibited in the GPI-PLD group. Nude mice models showed that the tumor growth and tumor weight [(1.87 ± 0.09) g] of the GPI-PLD group were significantly less than those of the blank control group [(2.20 ± 0.17) g] and the negative control group [(2.15 ± 0.09) g]. AST, ALT and AFP serum concentration in the GPI-PLD group were significantly lower than those of the control groups (P<0.05).
CONCLUSION
GPI-PLD can inhibit the proliferation of hepatoma cells and growth in vivo, and promote the apoptosis of hepatoma cells by reducing the activity of PI3K-Akt signaling pathway.
Animals
;
Apoptosis
;
Carcinoma, Hepatocellular
;
metabolism
;
pathology
;
Cell Line
;
Down-Regulation
;
Hep G2 Cells
;
Humans
;
Liver Neoplasms
;
metabolism
;
pathology
;
Mice
;
Mice, Nude
;
Phosphatidylinositol 3-Kinases
;
Phospholipase D
;
metabolism
;
Proto-Oncogene Proteins c-akt
;
metabolism
;
Signal Transduction
;
Transfection
9.Effect of ceramide on apoptosis and phospholipase D activity in FRTL-5 thyroid cells.
Byung Jun PARK ; Jong Hoon KIM ; Joong Soo HAN ; Poong Man JUNG
Experimental & Molecular Medicine 1999;31(3):142-150
Ceramide, a product of sphingomyelin hydrolysis, is now recognized as an intracellular lipid messenger, which mediates the effects of extracellular agents on cellular growth, differentiation and apoptosis. Recently, ceramide has been implicated in the regulation of phospholipase D (PLD). In this study, we examined the effects of ceramide on the activity and mRNA level of PLD during apoptotic process in FRTL-5 thyroid cells. C2-ceramide (N-acetyl sphingosine) induced apoptosis in FRTL-5 thyroid cells. Fluorescent staining showed that ceramide induced the typical features of apoptosis including condensed or fragmented nuclei. DNA fragmentation was also observed by agarose gel electrophoresis. Flow cytometric cell cycle analysis showed more clearly that ceramide induced apoptotic cell death in FRTL-5 thyroid cells. The treatment of FRTL-5 thyroid cells with thyroid-stimulating hormone (TSH) resulted in an increased PLD activity in a dose- and time-dependent manner. However, the TSH-induced increase in PLD activity was down-regulated within 2 h after ceramide treatment. Furthermore, the levels of PLD mRNA were found to be decreased throughout apoptotic process as inferred by reverse transcription-polymerase chain reaction. However, the decreases in PLD mRNA levels were not correlated with those in PLD activities after ceramide treatment. Taken together, these data suggest that ceramide inhibits the PLD activity in an early apoptotic phase and down-regulation of the levels of PLD mRNA may be implicated in apoptotic process in FRTL-5 thyroid cells.
Animal
;
Apoptosis/drug effects*
;
Cells, Cultured
;
DNA Fragmentation
;
Enzyme Activation/drug effects
;
Flow Cytometry
;
Gene Expression Regulation, Enzymologic/drug effects
;
Phospholipase D/metabolism*
;
Phospholipase D/genetics
;
RNA, Messenger/genetics
;
Rats
;
Rats, Inbred Strains
;
Sphingosine/pharmacology
;
Sphingosine/analogs & derivatives*
;
Thyroid Gland/enzymology
;
Thyroid Gland/drug effects*
;
Thyrotropin/pharmacology
10.Phospholipase Activities in Clinical and Environmental Isolates of Acanthamoeba.
The Korean Journal of Parasitology 2011;49(1):1-8
The pathogenesis and pathophysiology of Acanthamoeba infections remain incompletely understood. Phos-pholipases are known to cleave phospholipids, suggesting their possible involvement in the host cell plasma membrane disruption leading to host cell penetration and lysis. The aims of the present study were to determine phospholipase activities in Acanthamoeba and to determine their roles in the pathogenesis of Acanthamoeba. Using an encephalitis isolate (T1 genotype), a keratitis isolate (T4 genotype), and an environmental isolate (T7 genotype), we demonstrated that Acanthamoeba exhibited phospholipase A2 (PLA2) and phospholipase D (PLD) activities in a spectrophotometry-based assay. Interestingly, the encephalitis isolates of Acanthamoeba exhibited higher phospholipase activities as compared with the keratitis isolates, but the environmental isolates exhibited the highest phospholipase activities. Moreover, Acanthamoeba isolates exhibited higher PLD activities compared with the PLA2. Acanthamoeba exhibited optimal phospholipase activities at 37degrees C and at neutral pH indicating their physiological relevance. The functional role of phospholipases was determined by in vitro assays using human brain microvascular endothelial cells (HBMEC), which constitute the blood-brain barrier. We observed that a PLD-specific inhibitor, i.e., compound 48/80, partially inhibited Acanthamoeba encephalitis isolate cytotoxicity of the host cells, while PLA2-specific inhibitor, i.e., cytidine 5'-diphosphocholine, had no effect on parasite-mediated HBMEC cytotoxicity. Overall, the T7 exhibited higher phospholipase activities as compared to the T4. In contract, the T7 exhibited minimal binding to, or cytotoxicity of, HBMEC.
Acanthamoeba/*enzymology/genetics/*isolation & purification/physiology
;
Cell Adhesion
;
Cells, Cultured
;
Endothelial Cells/parasitology
;
Humans
;
Keratitis/*parasitology
;
Phospholipase D/genetics/*metabolism
;
Phospholipases A2/genetics/*metabolism
;
Protozoan Proteins/genetics/*metabolism
;
Soil/*parasitology